Status:
COMPLETED
Breakfast Consumption and Its Effects on Glycemic, Insulinemic and Non-Esterified Fatty Acids Responses
Lead Sponsor:
JeyaKumar Henry
Collaborating Sponsors:
General Mills
Conditions:
Glycemic Response
Eligibility:
MALE
40-65 years
Phase:
NA
Brief Summary
The aim of this study is to determine whether eating breakfast or having no breakfast has subsequent beneficial health effects, specifically in relation to glycemic response throughout the day and pos...
Detailed Description
This will be a randomised, crossover study with two treatments in total. 1.) Subjects given with breakfast, 2.) Subjects not given breakfast. Each of the two test visits will last for approximately 9 ...
Eligibility Criteria
Inclusion
- Chinese males
- BMI above 23.0 kg/m2
- Age between 40-65 years
- Normal blood pressure (\<140/90 mmHg)
- Fasting blood glucose of ≥5.6 mmol/L
- Self-reported regular breakfast consumers
Exclusion
- Have known glucose-6-phosphate dehydrogenase (G6PD) deficiency
- major chronic disease such as heart disease, cancer or diabetes mellitus
- taking insulin or drugs known to affect glucose metabolism
- Intentionally restrict food intake
- major medical or surgical event requiring hospitalization within the preceding 3 months
- Have taken antibiotics for 3 months before the study period
- Smoking
- Overnight shift workers
- Any known food allergy (eg. anaphylaxis to peanuts)
- Having active Tuberculosis (TB) or currently receiving treatment for TB
- Any known Chronic infection or known to suffer from or have previously suffered from or is a carrier of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV)
- Being a member of the research team or their immediate family members. Immediate family member is defined as a spouse, parent, child, or sibling, whether biological or legally adopted.
- Enrolled in a concurrent research study judged not to be scientifically or medically compatible with the study of the CNRC.
Key Trial Info
Start Date :
July 25 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 28 2019
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT03257059
Start Date
July 25 2017
End Date
March 28 2019
Last Update
May 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Nutrition Research Centre
Singapore, Singapore, 117599